Yayın:
The Value of F-18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for the Detection of Residual Breast Tumor or Axillary Metastasis after Neoadjuvant Chemotherapy in Invasive Ductal Carcinoma of the Breast

dc.contributor.authorBerberoğlu, Kezban
dc.contributor.orcid0000-0002-1796-3239
dc.date.accessioned2025-11-13T20:28:57Z
dc.date.issued2020-02-03
dc.identifier.doihttps://doi.org/10.4274/imj.galenos.2020.88714
dc.identifier.endpage46
dc.identifier.issn2148-094X
dc.identifier.issue1
dc.identifier.openalexW3004466533
dc.identifier.startpage42
dc.identifier.urihttps://hdl.handle.net/11421/11934
dc.identifier.urihttps://doi.org/10.4274/imj.galenos.2020.88714
dc.identifier.volume21
dc.language.isoen
dc.relation.ispartofİstanbul Medical Journal
dc.rightsopenAccess
dc.subjectAxilla
dc.subjectMedicine
dc.subjectBreast cancer
dc.subjectPositron emission tomography
dc.subjectRadiology
dc.subjectMetastasis
dc.subjectNeoadjuvant therapy
dc.subjectStandardized uptake value
dc.subjectBreast carcinoma
dc.subjectChemotherapy
dc.subjectNuclear medicine
dc.subjectCancer
dc.subjectInternal medicine
dc.subject.sdg3
dc.titleThe Value of F-18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for the Detection of Residual Breast Tumor or Axillary Metastasis after Neoadjuvant Chemotherapy in Invasive Ductal Carcinoma of the Breast
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5000428341

Dosyalar

Koleksiyonlar